Cambridge UK Pharma giant AstraZeneca is proving a variation on the proverbial enigma as it ponders the most appreciative ...

American Depositary Shares (ADSes) was lively on Tuesday, on news that its leadership intends to directly list its sock on a ...

AstraZeneca chief executive Sir Pascal Soriot is reportedly considering the move due to growing frustration with the UK's ...

Construction of AstraZeneca’s new global and R&D headquarters in Cambridge should have been completed last autumn – but builders are struggling to meet a revised deadline of May 2019.

AstraZeneca’s chief executive has discussed shifting the company’s stock market listing to the US in a move that would deal a ...

It was already a bad enough week for the Prime Minister Sir Keir Starmer and the Chancellor Rachel Reeves, what with the ...

AstraZeneca boss Sir Pascal Soriot (pictured) is thought to be mulling shifting its listing to New York due to growing ...

AstraZeneca Pharmaceuticals LP has been sued in the U.S. by a former senior director who claims the drugmaker refused to pay her nearly $130,000 in promised bonuses and stock options because she ...

AstraZeneca has today inaugurated its new, state-of-the-art headquarters in Cairo, showcasing its commitment to sustainable healthcare in Egypt and across the Middle East and Africa area. The ...

headquarters in rockville. THIS LAB ISN’T OPEN OR OPERATIONAL YET, BUT ONCE IT IS, THE FOLKS AT ASTRAZENECA BELIEVE IT IS GOING TO REVOLUTIONIZE CANCER TREATMENT. IT GIVES US HOPE.

Trading in AstraZeneca's (AZN-2.38%) American Depositary Shares ... the newspaper wrote that Soriot might also be mulling a move of AstraZeneca's headquarters from the U.K. to the U.S.